stockrowGuardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) EV/FCF
As of 5 November 2026, Guardant Health, Inc. (GH) trades at a EV/FCF of −84.7×. Over the past ten years it has ranged from −124× (December 2019) to −1.1× (October 2018); the current reading is higher than 17% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | −52.2× | — |
| FY2024 | −13.8× | — |
| FY2023 | −8.1× | — |
| FY2022 | −7.1× | — |
| FY2021 | −34.2× | — |
| FY2020 | −73.3× | — |
| FY2019 | −100× | — |
| FY2018 | −7.8× | — |
| FY2017 | −1.6× | — |
| FY2016 | −1.6× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | −97.7× | — |
| Jun 2026 | −78.8× | — |
| Mar 2026 | −49.1× | — |
| Dec 2025 | −52.2× | — |
| 32 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| GH Guardant Health, Inc. | −84.7× |
| ICLR ICON PLC compare | 22.6× |
| DGX Quest Diagnostics Incorporated compare | 23.8× |
| MEDP Medpace Holdings, Inc. compare | 25.7× |
| LH Labcorp Holdings Inc. compare | 29.8× |
| ILMN Illumina, Inc. compare | 31.3× |
| RVTY Revvity Inc. compare | 32.6× |
| MTD Mettler-Toledo International, Inc. compare | 41.4× |
| CRL Charles River Laboratories International, Inc. compare | 43.2× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement